Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

Deals > All

Total search results: 9868 | Ordered by Date (descending)
1 2 3 ... 97 98 99  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
United Kingdom (govt)–Congenica: bioinformatics, 201905 supply existent processing of samples for 100,000 Genomes Project for Genomics England 2019-05-14
Philogen–Consilium: public relations, 201905 service existent by CSC 2019-05-13
Philogen–SEVERAL: investment, 201905 financing round €62m from existing + new private investors 2019-05-13
TreeFrog Therapeutics–Andrew Lloyd Associates: public relations, 201905 service existent by ALA 2019-05-13
TreeFrog Therapeutics–SEVERAL: investment, 201905 financing round Series A €6.5m led by XAnge + incl Galia Geston et al 2019-05-13
MabVax Therapeutics–BioNTech: investment, 201905 acquisition €na of antibody assets + infrastructure + lab equipment in San Diego 2019-05-08
Therachon–Cowen: investment, 201905 existing investor Cowen 2019-05-08
Therachon–France (govt): investment, 201905 existing investors Bpifrance + Inserm Transfert Initiative 2019-05-08
Therachon–Novo Group: investment, 201905 existing investor Novo Holdings 2019-05-08
Therachon–OrbiMed: investment, 201905 existing investor OrbiMed 2019-05-08
Therachon–Pfizer: investment, 201905 existing investor Pfizer Ventures 2019-05-08
Therachon–Pfizer: investment, 201905– acquisition 100% $340m upfront + $470m milestones excl apraglutide development program 2019-05-08
Therachon–Tekla Capital: investment, 201905 existing investor Tekla Capital Management LLC 2019-05-08
Therachon–Versant Ventures: investment, 201905 existing investor Versant Ventures 2019-05-08
Confo Therapeutics–BioGeneration Ventures: investment, 201905 financing round Series A totalling €30m incl new + lead investor BGV 2019-05-07
Confo Therapeutics–Capricorn Venture Partners: investment, 201905 financing round Series A totalling €30m incl existing + co-investor Capricorn HTF 2019-05-07
Confo Therapeutics–Flanders (govt): investment, 201905 financing round Series A totalling €30m incl existing + co-investor PMV 2019-05-07
Confo Therapeutics–Fund+: investment, 201905 financing round Series A totalling €30m incl new + co-investor Fund+ 2019-05-07
Confo Therapeutics–Perceptive Advisors: investment, 201905 financing round Series A totalling €30m incl new + co-investor Perceptive Advisors 2019-05-07
Confo Therapeutics–Qbic: investment, 201905 financing round Series A totalling €30m incl existing + co-investor Qbic 2019-05-07
Confo Therapeutics–SEVERAL: investment, 201905 financing round Series A €30m led by BGV + co-led by Wellington Partners 2019-05-07
Confo Therapeutics–Univ Michigan: investment, 201905 financing round Series A totalling €30m incl existing + co-investor MINTS 2019-05-07
Confo Therapeutics–V-Bio Ventures: investment, 201905 financing round Series A totalling €30m incl existing + co-investor V-Bio Ventures 2019-05-07
Confo Therapeutics–VIB: investment, 201905 financing round Series A totalling €30m incl existing + co-investor VIB 2019-05-07
Confo Therapeutics–Wellington Partners: investment, 201905 financing round Series A totalling €30m incl new + co-lead investor Wellington Partners 2019-05-07
Promethera–Ci:z Investment: investment, 201905 financing round Series D totalling €39.7m incl new + co-investor Ci:z Investment LLP (JP) 2019-05-07
Promethera–Korea Investment Partners: investment, 201905 financing round Series D totalling €39.7m incl new + co-investor Korea Investment Partners 2019-05-07
Promethera–Medipal: investment, 201905 financing round Series D totalling €39.7m incl new + co-investor Medipal Holdings Corp 2019-05-07
Promethera–Mirae Asset: investment, 201905 financing round Series D totalling €39.7m incl new + co-investor Mirae Asset Capital 2019-05-07
Promethera–Mitsui: investment, 201905 financing round Series D totalling €39.7m incl existing + co-investor Mitsui & Co Global Investment Inc 2019-05-07
Promethera–SEVERAL: investment, 201905 financing round Series D totalling €39.7m incl Belgian private investors as co-investors 2019-05-07
Promethera–SEVERAL: investment, 201905 financing round Series D €39.7m co-led by Itochu Corp + Shinsei Capital Partners 2019-05-07
Promethera–Shinsei Capital: investment, 201905 financing round Series D totalling €39.7m incl new + co-lead investor Shinsei Capital Partners 2019-05-07
Promethera–Six Snow: investment, 201905 financing round Series D totalling €39.7m incl new + co-investor family office Six Snow 2019-05-07
Abide Therapeutics–Lundbeck: investment, 201905– acquisition $250m upfront + $150m milestones of Abide by Lundbeck 2019-05-06
Cutech (IT)–Symrise: investment, 201905 acquisition of Cutech Srl by Symrise 2019-05-06
Devicare–SEVERAL: investment, 201905– crowdfunding comapaign via Capital Cell platform 2019-05-06
Chemical Solutions Ltd–SGS: investment, 201905 acquisition of CSL by SGS 2019-05-03
Diem Labs–Devicare: medical device, 201905– collab marketing of Lit-Control in the US by Diem Labs LLC 2019-05-03
Amal Therapeutics–Boehringer: cancer drugs, 201905– collab clinical research combi study of ATP128 + BI754091 in colorectal cancer 2019-05-02
AstraZeneca–Transgene: cancer immunotherapy, 201905– collab + license option $10m upfront developm armed oncolytic vaccinia viruses using Invir.IO 2019-05-02
miRdetect–Bremen (govt): investment, 201905 seed financing round 7-digit € from HTGF + BBM Bremen + a private investor 2019-05-02
miRdetect–High-Tech Gründerfonds: investment, 201905 seed financing round 7-digit € from HTGF + BBM Bremen + a private investor 2019-05-02
miRdetect–OTHER: investment, 201905 seed financing round 7-digit € from HTGF + BBM Bremen + a private investor 2019-05-02
miRdetect–SEVERAL: investment, 201905 seed financing round 7-digit € from HTGF + BBM Bremen + a private investor 2019-05-02
National Cancer Center (JP)–Fluidigm: mass cytometry, 201905 supply existent use of Hyperion Imaging System for I-O research 2019-05-02
Transgene–Huntsworth: public relations, 201905 service existent by Citigate Dewe Rogerson 2019-05-02
Alentis Therapeutics–Bellevue: investment, 201904 financing round Series A totalling CHF12.5m incl co-lead investor BB Pureos Bioventures 2019-04-30
Alentis Therapeutics–BioMedPartners: investment, 201904 financing round Series A totalling CHF12.5m incl co-lead investor BioMedPartners 2019-04-30
Alentis Therapeutics–France (govt): investment, 201904 financing round Series A totalling CHF12.5m incl co-investor Bpifrance 2019-04-30
Alentis Therapeutics–Instinctif Partners: public relations, 201904 service existent media relations by Instinctif 2019-04-30
Alentis Therapeutics–Schroders: investment, 201904 financing round Series A totalling CHF12.5m incl co-investor Schroder Adveq 2019-04-30
Alentis Therapeutics–SEVERAL: investment, 201904 financing round Series A CHF12.5m co-led by BioMedPartners + BB Pureos Bioventures 2019-04-30
Enzyre–EU (govt): grant, 201904 EFRO grant €2m 2019-04-30
Enzyre–Optimum Strategic Communications: public relations, 201904 service existent by Optimum 2019-04-30
Enzyre–SEVERAL: investment, 201904 closing of seed financing round 2019-04-30
SGS–Veeva Systems: clinical research software, 201904– supply global implementation of Veeva Vault CTMS by SGS 2019-04-30
Canopy Biosciences–Ampersand: investment, 201904 strategic growth investment from Ampersand Capital Partners 2019-04-29
JnJ–Iktos: drug discovery services, 201904– collab using AI technology for small molecule drug discovery projects Janssen 2019-04-29
Zellkraftwerk–Canopy Biosciences: investment, 201904 acquisition of Zellkraftwerk GmbH by Canopy Biosciences 2019-04-29
ADC Therapeutics–Adagene: antibody technology, 201904– collab + license agreem €na using SAFEbody technology for ADC development 2019-04-24
InfanDx–Arnika Beteiligungen: investment, 201904 financing round totalling up to €5.3m incl existing + co-investor Arnika Beteiligungen GmbH 2019-04-24
InfanDx–CVG Capital: investment, 201904 financing round totalling up to €5.3m incl new investor CVG Capital GmbH 2019-04-24
InfanDx–Life Science Inkubator: investment, 201904 financing round totalling up to €5.3m incl existing + co-investor LSI-Pre-Seed-Fonds GmbH 2019-04-24
InfanDx–SEVERAL: investment, 201904 financing round up to €5.3m milestone-based from Bamed MAM + CVG Capital + LSI PreSeed + Arnika Beteiligungen 2019-04-24
LabCorp–Biocartis: molecular diagnostics, 201904– collab ww €na offering of Idylla platform + oncology assays by Covance for drug development 2019-04-23
Poseida Therapeutics–Malin Corp: investment, 201904 financing round Series C totalling $142m incl existing + co-investor Malin Corp 2019-04-22
Poseida Therapeutics–Novartis: investment, 201904 financing round Series C totalling $142m incl $75m from lead investor Novartis Pharma AG 2019-04-22
Poseida Therapeutics–SEVERAL: investment, 201904 financing round Series C $142m led by Novartis with $75m 2019-04-22
Genecast (CN)–HalioDx: cancer test, 201904– distribution excl of Immunoscore Colon Assay in China by Genecast 2019-04-19
Arrakis Therapeutics–HBM: investment, 201904 financing round Series B totalling $75m incl new + co- investor HBM Healthcare Investments 2019-04-18
Arrakis Therapeutics–Nextech Invest: investment, 201904 financing round Series B totalling $75m incl co-lead investor Nextech Invest 2019-04-18
Arrakis Therapeutics–SEVERAL: investment, 201904 financing round Series B $75m co-led by VenBio Partners + Nextech Invest 2019-04-18
Aidoc–SEVERAL: investment, 201904 financing round Series B $27m led by Square Peg Capital 2019-04-17
Aidoc–Square Peg Capital: investment, 201904 financing round Series B totalling $27m incl lead investor Square Peg Capital 2019-04-17
Boehringer–PureTech Health: cancer immunotherapy, 201904– colllab research up to $226m + royalties using lymphatic targeting platform for I-O drugs 2019-04-17
CytoSen Therapeutics–Kiadis: investment, 201904– acquisition merger in shares with 1.94m shares (7.4%) upfront plus 5.82 shares milestones 2019-04-17
Hookipa–Bank of America: financial services, 201904 supply service BofA Merrill Lynch is joint book-running manager for IPO 2019-04-17
Hookipa–RBC Capital Markets: financial services, 201904 supply service RBC Capital Markets is joint book-running manager for IPO 2019-04-17
Hookipa–Silicon Valley Bank: financial services, 201904 supply service SVP Leerink is joint book-running manager for IPO 2019-04-17
Hookipa–Van Lanschot: financial services, 201904 supply service Kempen is co-manager for IPO 2019-04-17
Bruker Corp–Univ Nijmegen: mass spectrometry, 201904– collab establishment of joint Center of Excellence for Translational Omics at RUMC TML 2019-04-16
Cevec–SEVERAL: investment, 201904 financing round Series D from new + existing investors 2019-04-16
Univ Nijmegen–Bruker Corp: mass spectrometer, 201904 supply existent several Bruker MS systems at RUMC TML 2019-04-16
Univ Nijmegen–Bruker Corp: mass spectrometer, 201904c supply acquisition of timsTOF Pro IM-MS system by RUMC TML 2019-04-16
Catalent–Leonard Green & Partners: investment, 201904– up to $1b convertible preferred stock with $650m issued 2019-04-15
ETH Zürich–Agilent: mass spectrometer, 201904 supply new 6546 LC/Q-TOF MS system to lab of Nicola Zamboni 2019-04-15
Paragon Bioservices–Catalent: investment, 201904– acquisition 100% for $1.2b in cash on cash-free + debt-free basis 2019-04-15
Gilead–Novo Group: drug development, 201904– collab clinical research for NASH combining semaglutide + cilofexor + firsocostat Novo Nordisk 2019-04-12
Evotec–Indivumed: cancer drug discovery, 201904– collab strategic precision medicine for new colorectal cancer drugs 2019-04-11
Miracogen (CN)–Synaffix: ADC technology, 201904– license up to $125m + royalties for GlycoConnect + HydraSpace ADC technologies to Shanghai Miracogen 2019-04-10
DKSH–Bruker Corp: analytical instruments, 201904– distribution excl extension for Bruker AXS products by DKSH in China 2019-04-09
Probiodrug–SEVERAL: investment, 201904 private placement €8.2m with 4.1m new shares at €2m led by Claus Christiansen et al. 2019-04-09
Theranexus–IRISA (FR): bioinformatics, 210904– collab using AI for targeting neuroglial interactions for drug discovery with Dyliss Group 2019-04-09
Phenex–Helmholtz: drug research, 201904– collab joint research in NASH + liver cancer metabolism with Heikenwälder Group at DKFZ 2019-04-05
Gesynta Pharma–SEVERAL: investment, 201904 financing round €6m led by Industrifonden + incl group of private life science investors 2019-04-04
Gesynta Pharma–Sweden (govt): investment, 201904 financing round totalling €6m incl lead investor Industrifonden 2019-04-04
AgomAb Therapeutics–Advent France Biotechnology: investment, 201904 financing round Series A totalling €21m incl co-lead investor Advent France 2019-04-03
AgomAb Therapeutics–Argenx: therapeutic antibodies, 201904– license excl to HGF-mimetic SIMPLE Antibodies developed in partnership 2019-04-03
AgomAb Therapeutics–Boehringer: investment, 201904 financing round Series A totalling €21m incl co-investor BIVF 2019-04-03
1 2 3 ... 97 98 99  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUK] Life-Sciences-UK.com – The Business Web Portal 600x80px

» top